These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28781296)

  • 21. Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome.
    Voermans NC; Verrijp K; Eshuis L; Balemans MC; Egging D; Sterrenburg E; van Rooij IA; van der Laak JA; Schalkwijk J; van der Maarel SM; Lammens M; van Engelen BG
    Connect Tissue Res; 2011 Oct; 52(5):422-32. PubMed ID: 21405982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.
    Egging D; van Vlijmen-Willems I; van Tongeren T; Schalkwijk J; Peeters A
    Connect Tissue Res; 2007; 48(2):93-8. PubMed ID: 17453911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the dermis zinc transporter ZIP13 promotes the mildness of fibrosarcoma by inhibiting autophagy.
    Lee MG; Choi MA; Chae S; Kang MA; Jo H; Baek JM; In KR; Park H; Heo H; Jang D; Brito S; Kim ST; Kim DO; Lee JS; Kim JR; Bin BH
    Sci Rep; 2019 Oct; 9(1):15042. PubMed ID: 31636298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered dermal fibroblast behavior in a collagen V haploinsufficient murine model of classic Ehlers-Danlos syndrome.
    DeNigris J; Yao Q; Birk EK; Birk DE
    Connect Tissue Res; 2016; 57(1):1-9. PubMed ID: 26713685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome.
    Miyake N; Kosho T; Mizumoto S; Furuichi T; Hatamochi A; Nagashima Y; Arai E; Takahashi K; Kawamura R; Wakui K; Takahashi J; Kato H; Yasui H; Ishida T; Ohashi H; Nishimura G; Shiina M; Saitsu H; Tsurusaki Y; Doi H; Fukushima Y; Ikegawa S; Yamada S; Sugahara K; Matsumoto N
    Hum Mutat; 2010 Aug; 31(8):966-74. PubMed ID: 20533528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormality of dermal collagen fibrils in Ehlers Danlos syndrome. Anticipation of the abnormality for the inherited hypermobile disorders.
    Kobayasi T
    Eur J Dermatol; 2004; 14(4):221-9. PubMed ID: 15319154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible involvement of zinc transporter ZIP13 in myogenic differentiation.
    Shoji M; Ohashi T; Nagase S; Yuri H; Ichihashi K; Takagishi T; Nagata Y; Nomura Y; Fukunaka A; Kenjou S; Miyake H; Hara T; Yoshigai E; Fujitani Y; Sakurai H; Dos Santos HG; Fukada T; Kuzuhara T
    Sci Rep; 2024 Apr; 14(1):8052. PubMed ID: 38609428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
    Syx D; Van Damme T; Symoens S; Maiburg MC; van de Laar I; Morton J; Suri M; Del Campo M; Hausser I; Hermanns-Lê T; De Paepe A; Malfait F
    Hum Mutat; 2015 May; 36(5):535-47. PubMed ID: 25703627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
    Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.
    Zweers MC; Dean WB; van Kuppevelt TH; Bristow J; Schalkwijk J
    Clin Genet; 2005 Apr; 67(4):330-4. PubMed ID: 15733269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome.
    Bristow J; Carey W; Egging D; Schalkwijk J
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):24-30. PubMed ID: 16278880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of the defective extracellular matrix of Ehlers-Danlos syndrome skin fibroblasts by dexamethasone.
    Moro L; Colombi M; Zoppi N; Ghinelli A; Barlati S
    Cell Biol Int; 1994 Jan; 18(1):29-37. PubMed ID: 8186768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome.
    Chen F; Guo R; Itoh S; Moreno L; Rosenthal E; Zappitelli T; Zirngibl RA; Flenniken A; Cole W; Grynpas M; Osborne LR; Vogel W; Adamson L; Rossant J; Aubin JE
    J Bone Miner Res; 2014 Jun; 29(6):1412-23. PubMed ID: 24443344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
    Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous histologic features in Ehlers-Danlos syndrome: study of 21 patients.
    Sulica VI; Cooper PH; Pope FM; Hambrick GW; Gerson BM; McKusick VA
    Arch Dermatol; 1979 Jan; 115(1):40-2. PubMed ID: 760655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a functional skin matrix requires deposition of collagen V heterotrimers.
    Chanut-Delalande H; Bonod-Bidaud C; Cogne S; Malbouyres M; Ramirez F; Fichard A; Ruggiero F
    Mol Cell Biol; 2004 Jul; 24(13):6049-57. PubMed ID: 15199158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
    Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
    Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herbal formula Astragali Radix and Rehmanniae Radix exerted wound healing effect on human skin fibroblast cell line Hs27 via the activation of transformation growth factor (TGF-β) pathway and promoting extracellular matrix (ECM) deposition.
    Zhang Q; Fong CC; Yu WK; Chen Y; Wei F; Koon CM; Lau KM; Leung PC; Lau CB; Fung KP; Yang M
    Phytomedicine; 2012 Dec; 20(1):9-16. PubMed ID: 23083814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question].
    Fichard A; Chanut-Delalande H; Ruggiero F
    Med Sci (Paris); 2003 Apr; 19(4):443-52. PubMed ID: 12836217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Collagen type I, III, IV and V and fibronectin in skin biopsies of patients with Ehlers-Danlos syndrome and cutis laxa].
    Shekhonin BV; Semiachkina AN; Makkaev KhM; Domogatskiĭ SP; Idel'son GL
    Arkh Patol; 1988; 50(12):41-8. PubMed ID: 3074749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.